Bavarian Nordic Paul Chaplin steps down as CEO of Bavarian

Bavarian Nordic Paul Chaplin steps down as CEO of Bavarian

Bavarian Nordic Chairman Resigns Following Collapsed Takeover Bid

Bavarian Nordic A/S, a Danish vaccine manufacturer, announced the resignation of its chairman, Luc Debruyne, following the collapse of a contentious take-private deal led by private equity firms Nordic Capital and Permira. Debruyne stepped down with immediate effect on November 14, 2025, citing the failed acquisition process as a key factor in his decision.

The proposed $1.2 billion takeover, initially supported by Bavarian’s board, faced sustained opposition from shareholders throughout 2025. Despite the bidders increasing their offer price and reducing the required acceptance threshold twice, the deal failed to secure sufficient shareholder approval. Nordic Capital and Permira formally withdrew their bid in early November, ending months of uncertainty.

Investor dissatisfaction with Debruyne’s leadership intensified during the prolonged process. Critics argued he misjudged shareholder sentiment and underestimated resistance to the privatization, which some investors viewed as undervaluing the company’s long-term potential. The fallout eroded trust in his stewardship, prompting his resignation.

Anne Louise Eberhard, previously vice chair, has been appointed as the new chairperson to stabilize the company’s governance. Eberhard, a veteran in life sciences and former executive at Novo Nordisk, brings extensive industry experience to the role. Bavarian Nordic’s board emphasized a commitment to "restoring investor confidence" and focusing on operational growth.

The failed takeover has sparked broader questions about corporate governance at Bavarian Nordic. With a market capitalization of approximately $950 million as of late November 2025, the company now faces pressure to demonstrate value creation through its pipeline of cancer immunotherapies and pandemic preparedness initiatives.

Analysts note that the transition in leadership could influence strategic decisions in 2026, particularly regarding potential partnerships or capital-raising efforts. For now, Bavarian Nordic remains focused on navigating post-takeover uncertainty while addressing shareholder concerns.

According to Bloomberg reporting: Bloomberg, November 14, 2025.

(Word count: 300)